glp 1 and atrial fibrillation Glucagon‐like peptide‐1 receptor agonist semaglutide reduces incidence: A systematic review meta‐analysis - Saglietto - 2024 - European Journal of Clinical Investigation GLP-1RA in Different HFpEF Phenotypes

A review of its characteristics and therapeutic use in cardiac ischemya and in primary and secondary deficits of carnitine, associated to fatty acid metabolism

Using a weight loss tracking system alongside meal planning can significantly improve your results

However, certain populations require medical supervision: those with personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, severe kidney disease, or active pancreatitis require specialized medical evaluation before starting therapy

What our patients say

A randomized pilot study comparing zero-calorie alternate-day fasting to daily caloric restriction in adults with obesity